Viewing Study NCT04573556


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-20 @ 3:53 PM
Study NCT ID: NCT04573556
Status: COMPLETED
Last Update Posted: 2022-04-05
First Post: 2020-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.
Sponsor: Eisai Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sleep Initiation and Maintenance Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None E2006 View
None Lemborexant View
None Insomnia View
None Non-interventional View
None Dayvigo View